1. Home
  2. RLAY vs CSTM Comparison

RLAY vs CSTM Comparison

Compare RLAY & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.18

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$29.56

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
CSTM
Founded
2015
2010
Country
United States
France
Employees
N/A
11500
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.4B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
RLAY
CSTM
Price
$19.18
$29.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
4
Target Price
$19.50
$30.75
AVG Volume (30 Days)
2.5M
1.7M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
31.78
405.26
EPS
N/A
1.42
Revenue
$15,355,000.00
$8,449,000,000.00
Revenue This Year
N/A
$21.46
Revenue Next Year
$324.03
$0.50
P/E Ratio
N/A
$20.01
Revenue Growth
53.44
15.19
52 Week Low
$3.03
$13.06
52 Week High
$20.79
$36.99

Technical Indicators

Market Signals
Indicator
RLAY
CSTM
Relative Strength Index (RSI) N/A 46.80
Support Level N/A $27.80
Resistance Level N/A $30.75
Average True Range (ATR) 0.00 1.16
MACD 0.00 0.12
Stochastic Oscillator 0.00 62.43

Price Performance

Historical Comparison
RLAY
CSTM

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

About CSTM Constellium SE (France)

Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.

Share on Social Networks: